Skip to content

A study of the efficacy of electrotherapy for tumor-associated sarcopenia using multiparametric ultrasound indexes

A study of the efficacy of electrotherapy for tumor-associated sarcopenia using multiparametric ultrasound indexes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001108
Enrollment
Unknown
Registered
2025-06-03
Start date
2024-02-01
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia

Interventions

Electroacupuncture combined with nutritional intervention group:Electroacupuncture combined with nutritional intervention
Nutrition alone intervention group:Nutritional interventions

Sponsors

Nanjing Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with tumors diagnosed by pathological examination who are expected to survive for more than three months; Patient has good active mobility balance and coordination; Voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) sarcopenia with dysfunction in sarcopenia stratification; (2) Those who are afraid of acupuncture due to psychological factors and cannot accept acupuncture treatment; (3) Prone to various acute complications; (4) tumor cachexia status and tumor depletion; (5) Neurodisuse sarcopenia.

Design outcomes

Primary

MeasureTime frame
6m pace;Multiparametric ultrasound indicators;Limb muscle index;Dominant hand grip;

Secondary

MeasureTime frame
body mass index;Body fat percentage;Short Physical Performance Battery;MiniNutritional Assessment;

Countries

China

Contacts

Public ContactZhangcairong

Nanjing Traditional Chinese Medicine Hospital

njszyyzcr@163.com18951755167

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026